---
schema_version: "secwatch.filing_event.v1"
accession: "0001606498-21-000046"
form_type: "8-K"
ticker: "AVNS"
cik: "0001606498"
company_name: "AVANOS MEDICAL, INC."
filed_at: "2021-08-03T23:59:59+00:00"
generated_at: "2026-06-29T23:22:16.347426+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Avanos Q2 net sales $186M (+14% YoY); guides FY adj. EPS to $1.10–$1.20 from $1.10–$1.25

## Summary
- Q2 diluted EPS $0.78 vs. loss of $0.06; adjusted diluted EPS $0.21 vs. $0.13.
- Gross margin fell to 46% (59% adj.) due to higher freight and manufacturing inefficiencies.
- Full-year net sales growth outlook maintained at 2%–4% constant currency; adj. EPS guidance narrowed to $1.10–$1.20.
- Entered Deferred Prosecution Agreement with DOJ on July 6 resolving criminal investigation into MicroCool surgical gowns.
- Board member Heidi Kunz resigned July 29 to pursue other opportunities; no disagreements.

## SEC filing metadata
- accession: 0001606498-21-000046
- form_type: 8-K
- ticker: AVNS
- cik: 0001606498
- company_name: AVANOS MEDICAL, INC.
- filed_at: 2021-08-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649821000046/0001606498-21-000046-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606498/000160649821000046/avns-20210729.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606498-21-000046
- JSON: https://secwatch.observer/filing/0001606498-21-000046.json
- Plain text: https://secwatch.observer/filing/0001606498-21-000046.txt

## Key facts
- Executive change
  Heidi Kunz resigned as Director at AVANOS MEDICAL, INC..
  - Action: resigned
  - Role: Director
  source text: On July 29, 2021, Heidi Kunz notified the Company that she was resigning from the Board of Directors to pursue other business opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1606498/000160649821000046/0001606498-21-000046-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.